Mammalian Target of Rapamycin Inhibition in Trypanosoma cruzi-Infected Macrophages Leads to an Intracellular Profile That Is Detrimental for Infection

The causative agent of Chagas’ disease, Trypanosoma cruzi, affects approximately 10 million people living mainly in Latin America, with macrophages being one of the first cellular actors confronting the invasion during T. cruzi infection and their function depending on their proper activation and po...

Descripción completa

Detalles Bibliográficos
Autores principales: Rojas Márquez, Jorge David, Ana, Yamile, Baigorrí, Ruth Eliana, Stempin, Cinthia Carolina, Cerban, Fabio Marcelo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5826284/
https://www.ncbi.nlm.nih.gov/pubmed/29515594
http://dx.doi.org/10.3389/fimmu.2018.00313

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5826284/
https://www.ncbi.nlm.nih.gov/pubmed/29515594
http://dx.doi.org/10.3389/fimmu.2018.00313

Ejemplares similares